What is DRUG's dilution risk score?

DRUG has a latest available DilutionScore record of 45/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for DRUG, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for DRUG?

DilutionWatch tracks 25 SEC filing types for DRUG including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect DRUG shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For DRUG, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for DRUG tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for DRUG. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

DRUG Dilution Risk Score: 45/100 (component-limited)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

40

📊Float Risk—

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for DRUG.

🔔 Track DRUG — Get forecast alerts →

Market Data

Market Cap$864.15M

Shares Outstanding4.52M

FloatN/A

Cash$224.50M

Debt$59.5K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 79.7% shares (2026Q1 vs prior)

93 institutional holders · 11.89M shares

#1 JANUS HENDERSON GROUP PLC 2.57M shares

#2 Vivo Capital, LLC 1.11M shares

#3 Cormorant Asset Management, LP 1.06M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest890.8K

Days to Cover4.0

% of FloatN/A

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

No recent SEC insights

Recent News

No recent news

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

More Research for DRUG

DRUG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

DRUG — Bright Minds Biosciences Inc. Dilution Risk Tracker